Description: 

This activity offers a multidisciplinary overview of molecular and genetic testing and its role in guiding evidence-based treatment decisions. Participants will learn how to select appropriate diagnostic tests following pathology review and apply results to inform systemic treatment strategies, including chemotherapy, immunotherapy, and hormone therapy. The course also explores key components of comprehensive care, including surgical management, imaging approaches to assess disease extent, and the integration of palliative care, clinical trials, and supportive services to optimize patient outcomes.

Target Audience: 

Nurse Practitioner (NP)

Physicians (MD or DO)

Physician Assistant (PA)

Other Healthcare Professionals

Learning Objectives: 

Upon completion of this learning activity, participants should be able to:

1. Select appropriate molecular and genetic tests following pathology review to guide evidence-based treatment decisions.
2. Interpret pathology findings and imaging results to accurately assess disease characteristics and extent.
3. Apply molecular and diagnostic data to determine optimal systemic treatment strategies, including chemotherapy, immunotherapy, and hormone therapy.
4. Integrate surgical options, palliative care, and supportive services into comprehensive, patient-centered care plans. Identify appropriate clinical trial opportunities and supportive resources to enhance patient outcomes.

Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):

Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:

Social Determinants of Health (SDOH)/Cultural or Linguistic Considerations:

• J Natl Compr Canc Netw . 2023 Jan;21(1):21-26. doi: 10.6004/jnccn.2022.7073. https://pubmed.ncbi.nlm.nih.gov/36634609/

Implicit Bias Considerations (as it relates to the content):                                                                                    

• Fiscella K, Epstein RM, Griggs JJ, Marshall MM, Shields CG (2021) Is physician implicit bias associated with differences in care by patient race for metastatic cancer-related pain? PLoS ONE16(10): https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0257794

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.   

– Provider Designee/Verification: Fozia Ferozali, Ed.D. 
 

Faculty List: 
Committee Member(s)
Royce Chrys, MD, DABR has no relevant financial relationships to disclose at this time.

Planner(s)
Mark Goldsmith has no relevant financial relationships to disclose at this time.
Samantha Volek has no relevant financial relationships to disclose at this time.

Speaker(s)
Lorelle Carlley, M.D. has no relevant financial relationships to disclose at this time.
Royce Chrys, MD, DABR has no relevant financial relationships to disclose at this time.
Mark Goldsmith  has no relevant financial relationships to disclose at this time.